Current calls, week 21, 2023
Tips from Grants Office regarding current calls
Swedish and Nordic calls
Forskarstipendium - Svensk Förening för Övre Abdominell Kirurgi (SFÖAK)
Den som har en kliniskt inriktad forskning inom övre abdominell kirurgi är välkommen att söka SFÖAK:s forskarstipendium om 30 000 kr.
Closing date: May 31, 2023
Forskningsmedel - Stiftelsen Psoriasisfonden och Stiftelsen Gösta A Karlssons 60 års fond
Stödjer vetenskapliga projekt som syftar till att öka kunskapen om psoriasis och psoriasisartrit, psoriasissjukas levnadsvillkor och utveckla bättre behandlingsmetoder. Det går ej att söka medel till samma projekt från båda fonderna, dock kan samma forskare/team söka medel från båda fonderna till olika projekt. Gösta A Karlssons 60 års fond tar företrädesvis emot ansökningar för projekt i uppstartsfas; Psoriasisfonden för projekt i alla faser.
Closing date: June 1, 2023
Dermatology research projects worldwide - LEO Foundation
The Foundation welcomes applications for research projects that improve the understanding of skin biology as well as the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms. Applications for projects that address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved are also welcome. The Foundation does not support projects on skin cancer. Skin cancer models may be permitted if used as tools to investigate other aspects of skin or skin diseases. Research can be carried anywhere in the world. The typical amount approved for funding of a research grant is DKK 2-4 million.
Closing date: June 23, 2023
Research grants - the Swedish Fund for Research Without Animal Experiments
The Swedish Fund for Research Without Animal Experiments invites pre-proposals for its research grants for the prevention of animal testing. The Swedish Fund for Research Without Animal Experiments awards grants to research projects aiming to develop new methods that can replace animal experiments. Grants are almost exclusively awarded to projects in Sweden and/or international projects including a Swedish partner. Other international projects that may have an impact on the Swedish research community, legislation or education may also be considered for funding.
Closing date: June 30, 2023
Grants for research on amyotrophic lateral sclerosis (ALS) - Ulla-Carin Lindquist Foundation for ALS-Research
The Foundation funds research on amyotrophic lateral sclerosis as well as information spreading projects in Sweden and abroad. The total budget is worth approximately SEK 5 million.
Closing date: August 1, 2023
Research grants - Rambøll Foundation
Rambøll Denmark invites applications for grants from the Rambøll Foundation. These promote research, studies and higher education, particularly within the technical and natural sciences. More sociological-oriented research will also be considered.
Closing date: August 15, 2023
Forskningsanslag - Radiumhemmets Forskningsfonder
Radiumhemmets Forskningsfonder stödjer klinisk patientnära cancerforskning och translationell forskning inom Region Stockholm. Valet av forskningsinriktning grundar sig i att den basala och prekliniska forskningen har flera andra anslagskällor medan den patientnära forskningen har svårare att få ekonomiskt stöd.
Closing date: September 1, 2023
Research grants - Nordic Cancer Union
The Nordic Cancer Union (NCU) provides funding to support and stimulate collaborative cancer research within the Nordic countries. The applying researcher’s and collaborators involved in the project must be working in at least three, and preferably several different Nordic countries. The research project must be cancer relevant and uniquely suited to be carried out within the Nordic countries, and the effect of collaboration should be synergistic. NCU research grants are provided for one year. Further support for the project will require a new, yearly application. As a general rule, project funding can only be renewed twice; a project can obtain funding from the NCU for a total of maximum three years.
Closing date: September 1, 2023
Forskningsanslag – Alzheimerfonden
Anslag stöder forskning inom området Alzheimers sjukdom och andra demenssjukdomar. Följande projekt prioriteras: med potential att på kort eller lång sikt kunna stoppa sjukdomsutvecklingen vid Alzheimers sjukdom; med inriktning på att diagnosticera sjukdomen i tidigt skede; möjliggör behandlingen och rehabiliteringen av Alzheimerspatienter; där klinisk nytta tydligt kan beskrivas; där samverkan mellan forskningsgrupper förstärker projektets kvalitet och genomförbarhet.
Closing date: September 15, 2023
The Novo Nordisk Foundation is seeking nominations for the 2024 Novo Nordisk Prize!
We invite you to nominate the bright minds behind the biomedical breakthroughs that have shown true translational impact and advanced medical sciences.
Please submit your nomination via the electronic nomination form until 15 June, 2023.
Novo Nordisk Prize 2024 Nomination Form - Novo Nordisk Fonden
The Novo Nordisk Prize
In 2024, the Prize is of DKK 5 million (appr. EUR 672,000) and consists of a DKK 4,5 million (or appr. €605,000) research grant, a personal award of DKK 0,5million (or appr. €67,000). The Foundation will grant an additional DKK 0,5 million for hosting an international symposium within the awardee's field(s) of research in Copenhagen Denmark.
Spread the Word
Forward this email to your colleagues, or any person or organization that might want to nominate a scientist. You can also visit our social media channels to share the call there.
Questions
Questions are welcome at novonordiskprize@novo.dk.
European calls
MSCA Postdoctoral Fellowships 2023
The MSCA 2023 Postdoctoral Fellowships is now open with closing date on September 13th 2023. With the MSCA Postdoc Fellowships you can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.
Closing date: 13 September 2023.
MSCA Postdoc Fellowships BOOTCAMP
For those who apply with KI as Host Organization to the Marie Skłodowska Curie Actions Postdoctoral Fellowships, KI Grants Office offers a workshop series (Bootcamp) for proposal writing which starts on June 15th. The Bootcamp is seven series in total with one full day on June 15th and six afternoon sessions in August.
Registration requirements and information
MSCA Doctoral Networks 2023 Call
The MSCA Doctoral Networks aim to train creative, entrepreneurial, innovative and resilient doctoral candidates, able to face current and future challenges and to convert knowledge and ideas into products and services for economic and social benefit.
The MSCA Doctoral Networks will raise the attractiveness and excellence of doctoral training in Europe. They will equip researchers with the right combination of research-related and transferable competences and provide them with enhanced career perspectives in both the academic and non-academic sectors through international, inter-sectoral and interdisciplinary mobility combined with an innovation-oriented mind-set.
The call will open on May 30th.
Closing date: 28 November 2023.
Information Event on MSCA Doctoral Networks 2023
The European Commission and the European Research Executive Agency are organising an online Information Event on Doctoral Networks 2023 on 14 June, 9.30 CEST to 12.30 CEST. This webinar aims at informing all potential applicants about the MSCA Doctoral Networks 2023 call modalities and novelties and at encouraging applicants to submit proposals for Industrial Doctorates and Joint Doctorates.
The session will be organised online and accessible upon registration. The event will be opened with a welcome address and some introductory remarks, followed by the main presentation of the call’s novelties. Participants will have the opportunity to raise their questions through Slido, in advance of the event (as of 1 June 2023) and during the question and answers session at the end of the event.
Research grants - Cure Parkinson's Trust, GB
The Cure Parkinson's Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to cure Parkinson's disease. Applications must be for research that slows, stops or reverses underlying disease progression. Priority is given to research which has potential to translate into the clinic within five years.
Applications are invited world wide.
Closing date: 5 June 2023
Short-term fellowships
European Federation of Immunological Societies (EFIS), INT
These support transnational scientific collaboration and advanced training in techniques or methodologies.
Deadline Information: The EFIS Board evaluates applications at its periodic meetings, held every 3-4 months.
Recurrence: This call is repeated 4 times a year.
Closing date: 9 June 2023
Study Group Research Funding - European Society of Clinical Microbiology and Infectious Diseases (ESCMID), INT
This funding is exclusively available for official ESCMID Study Group research projects in the fields of clinical microbiology and infectious diseases.
Closing date: 19 July 2023
Research grant - European Leukodystrophy Association, INT
These grants support research that addresses knowledge gaps in the field of leukodystrophies. Preference is given to clinical trials and clinical trial readiness projects.
Themes proposed in the 2023 call for proposals will focus on unmet needs in the field of leukodystrophies.
Research Topics of Interest include:
- Clinical trial / clinical trial readiness for leukodystrophies including the development of longitudinal outcome measures, biomarker characterization, imaging modalities and pharmacodynamics /pharmacokinetic studies.
- Preclinical studies specifically testing therapies (gene, cell, enzyme or pharmacologic therapies) for leukodystrophies.
- Developing animal or cell-based models (e.g. patient derived iPSC) relevant to human leukodystrophies.
- Study of mechanisms responsible for leukodystrophies, in order to identify new therapeutic approaches.
Closing date 1 June 2023
Project Grants - European Society of Contraception and Reproductive Health (ESC), INT
The ESC will provide funding to support a project that has a scientific basis with a described relevant outcome(s) and is related to the aims of the ESC. Examples include: research into methods or provision of contraception, sexual and reproductive health; validated questionnaires to understand uptake or utlization of a method or procedure; or needs assessment withing a community or locale.
Closing date 11 June 2023
BactiVac catalyst pump priming projects - University of Birmingham, GB
The BactiVac Network, based at the University of Birmingham, invites proposals for its catalyst pump priming projects scheme. This promotes new collaborations, in particular involving LMIC partners, resulting in preliminary data necessary to attract further, more substantial funding leading to long-lasting and beneficial partnerships that grow bacterial vaccinology. The aim is to accelerate the development and progression of vaccines against bacterial pathogens, particularly those of direct relevance to LMICs. Projects that achieve the following are prioritised:
- facilitate onward progression of bacterial vaccines along the pipeline to licensure;
- offer robust solutions to overcome the difficult preclinical to clinical transition;
- advance the ability to tackle the global challenge of antimicrobial resistance;
- involve BactiVac partnerships, particularly new partnerships, with a long-term work plan;
- include LMICs or industrial partners;
- demonstrate a clear pathway to impact;
- have realistic plans in place to demonstrate intellectual property has been considered;
- include plans for achieving further substantive funding at the end of the project.
Closing date 18 June 2023
Daytime sleepiness research grant - European Sleep Research Society, INT
The European Sleep Research Society invites applications for its daytime sleepiness research grant. This supports a young physician working in the field of daytime sleepiness.
Applicants must be working in Europe, be less than 10 years post-terminal degree and preferably be members of the society.
The grant is worth €10,000.
Closing date 24 June 2023 (Forecast)
Postdoc research grants - European Society for Paediatric Research (ESPR), INT
The European Society for Paediatric Research invites applications for its postdoc research grants. These support a research project for established researchers at an early stage of their career in all fields related to paediatrics.
Applicants must be members of the society within six years of having received their PhD qualifications in biomedical sciences, medicine or life sciences.
Grants are worth up to €25,000 each.
Closing date 01 August 2023 (Forecast)
Stipends for Ukrainian researchers - Multidisciplinary European Low Dose Initiative (MELODI), INT
The Multidisciplinary European Low Dose Initiative invites applications for its stipends for Ukrainian researchers. This supports Ukrainian scientists in undertaking research related to the strategic research agenda of the Multidisciplinary European Low Dose Initiative.
Eligible applicants must be of Ukrainian citizenship, aged under 65, living either in Ukraine or having fled the war to any country, except Russia and Belarus. Stipends will be paid directly to the awardee and the research project must be based in a MELODI member institute or in Ukraine in collaboration with a MELODI member institute.
Two stipends worth €30,000 each are available.
Closing date 31 August 2023 (Forecast)
Research grants - Merck KGaA, DE
Merck invites applications for its research grants. These support innovative scientific research in challenging areas of future importance. Grants are available in the following focus topics:
•drug discovery - three grants worth up to €500,000 each per year for three years, with the option of extension;
•artificial intelligence for predictive diagnostics and therapeutic target discovery - one grant worth between €100,000 and €300,000 per year for two years, with the option of extension;
•chemistry in the cloud - rapid synthesis through automation - one grant worth €100,000 per year for three years;
•innovation within green chemistry - one grant worth €100,000 for one year, with potential further collaboration;
•sustainability in healthcare R&D - one grant worth €100,000 for one year.
Scientists at any career stage, who are affiliated with any research institution, university or company worldwide, may apply. Candidates may apply for more than one grant or submit their application for more than one focus topic.
Closing date 31 August 2023 (Forecast)
Research fellowship - European Academy of Neurology, INT
The European Academy of Neurology invites applications for its research fellowship programme. This supports training and experience for European neurologists in any area of basic, clinical or applied research in neuroscience. Two types of fellowships are available:
•research training fellowship for the completion of a higher degree, a grant application or peer-reviewed publication, typically lasting between six and 12 months;
•research experience fellowship for individuals who might otherwise not have the opportunity to gain high quality research experience but who wishes to pursue a research career, with consideration also given to more experienced clinicians or researchers requiring training in a specific research methodology or technique not currently available in their own country and of clear value to their home department, typically lasting up to six months.
Closing date 31 August 2023
US calls
Federal Funding
CDMRP - Melanoma Research Program (MRP)
Funded programs: Focused Program Award, Melanoma Academy Scholar Award, Mid-Career Accelerator Award, Team Science Award, Idea Award.
Upcoming deadlines:
LOI – 31st August, 5pm ET; Full application – 22nd September, 11:59 ET. Focused Program Award, Melanoma Academy Scholar Award, Mid-Career Accelerator Award, Team Science Award.
LOI – 10th July, 5pm ET; Full application - 22nd September, 11:59 ET. Idea Award.
Abstract: The vision of the MRP is to prevent melanoma initiation and progression. The mission of the MRP is to support development of earlier interventions to enhance mission readiness and diminish melanoma burden on Service Members, Veterans, their families, and the American public. The FY23 appropriation is $40M. Studies involving non-melanoma skin cancers are not allowed under the FY23 MRP.
NIH- International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-AI-23-023
Upcoming deadlines: August 02, 2023; August 02, 2024; August 01, 2025
Abstract: The purpose of this Funding Opportunity Announcement (FOA) is to support applications for high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply. Eligibility status of applicant organizations will be determined by the World Bank Classification list at the time of application submission.
NIH - Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: PAR-23-169
Upcoming deadlines: August 02, 2023; August 02, 2024; August 01, 2025
Abstract: The purpose of this reissued Notice of Funding Opportunity (NOFO) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this NOFO supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated “Go/No-Go” criteria by the end of Year 2.
More info: PAR-23-169: Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (nih.gov)
NIH - Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-AI-23-026
Upcoming deadlines: August 02, 2023
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to advance synthetic nucleic acid platforms for the rapid development and iterative testing of active and passive immunization strategies for HIV prevention, treatment, and cure. This NOFO will use a milestone-driven, biphasic award mechanism. Transition to the second phase will depend on the successful completion of milestones.
NIH - Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-AI-23-029
Upcoming deadlines: October 11, 2023
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to support mechanistic studies of the early stage of Mycobacterium tuberculosis (Mtb) infection, with and without HIV, to identify interventional targets for vaccine and host-directed therapies.
NIH - Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-AG-24-038
Upcoming deadlines: October 23, 2023
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate the use of existing biospecimens and datasets (i.e., secondary analysis) which will increase our understanding of the clinical significance of clonal hematopoiesis (CH) mutations, their causality, directionality, relationships with different human aging phenotypes, and underlying biological mechanisms. CH is a condition related to aging wherein clonal expansion of hematopoietic cells driven by somatic mutations increases markedly with age in humans. While associations of CH with higher risk for age-related cardiovascular disease have been reported, an in-depth understanding of the interplay of CH mutations, aging, and physiological/clinical outcomes is needed for potential risk stratification for other age-related diseases, therapeutic target identification, and development of therapeutic interventions to promote healthy aging. In this regard, virtually little is known about the relationship between CH mutations and exceptionally healthy aging phenotypes.
New data and specimen collection (e.g., follow-up of individuals for additional phenotypic characterization and biospecimen collection, generation of sequencing data) to supplement existing datasets is allowed when essential for addressing the specific aims of the proposed study. Studies should consider both potential deleterious and protective effects of CH mutations and the molecular mechanisms underpinning pleiotropic effects of CH in aging. Analysis of biospecimens from clinical trials focused on age-related outcomes is also strongly encouraged to assess and clarify the relationship of CH to treatment effects and to evaluate the clinical utility of CH screening in clinical practice for risk prediction and prognosis for age-related disease.
NIH- Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-DA-24-028
Upcoming deadlines: November 02, 2023
Abstract: This notice of funding opportunity (NOFO) will support research to improve our understanding of psychedelic drug mechanisms in the context of substance use disorders (SUDs). This NOFO will also support the design and synthesis of chemical biology tools and probes to aid basic research on psychedelics and their translational pharmacology.
This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Applicants are strongly encouraged to read the FOA instructions carefully and view the available PEDP guidance material.
NIH - Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-AI-23-029
Upcoming deadlines: October 11, 2023
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to support mechanistic studies of the early stage of Mycobacterium tuberculosis (Mtb) infection, with and without HIV, to identify interventional targets for vaccine and host-directed therapies.
Foundation
Chan Zuckerberg Initiative (CZI)- Request for Applications: Deep Tissue Imaging
Upcoming deadlines: LOI (July 11, 2023); Invitation to full proposal (August 15, 2023); Full proposal (September 26, 2023).
The Chan Zuckerberg Initiative (CZI) invites applications for four-year projects in the field of deep tissue imaging. To gain a deeper mechanistic understanding of biological systems, CZI’s Imaging program aims to visualize and measure them across biological scales and in their biological context. This Request for Applications (RFA) seeks to drive development of imaging technology focused on obtaining cellular resolution readouts within complex living organisms. This grant program will advance the field of deep tissue imaging, which aims to obtain cellular resolution in complex tissue and through skin and bone. While an upper budget limit has not been set, requests larger than $2.5 million USD total costs will receive additional scrutiny, and may undergo additional budget adjustments.
Website: Deep Tissue Imaging RFA (Phase 2) - CZ Science (chanzuckerberg.com)
International Myeloma Foundation (IMF) - Brian D. Novis Research Grant
The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis. This year's awards will be $50,000 each for the junior grant and $80,000 for the senior grant.
Upcoming deadlines: August 28, 2023.
Website: Apply for an IMF Research Grant | Int'l Myeloma Fndtn